The hernia mesh devices market size is estimated to be USD 4912.5 million in 2022 and is expected to witness a CAGR of 6.85% during the forecast period 2023-2033. Developments such as self-fixating meshes and articulating fixation, higher incidence of hernias are smoking, poor nutrition, genetics, and lifestyle changes are projected to drive the market growth in near future. The high prevalence of hernias worldwide and enhanced outcomes for patients from the use of meshes, which shorten operation and recuperation times are some of the drivers of the market’s expansion. However, are predicted to limit market growth are expected to restrain the market growth.

Technological developments are expected to propel the market growth during the forecast period. Hernia mesh technology has advanced significantly during the past few years. To solve the issues that arise during the laparoscopic procedure, innovations including articulating fixation devices and self-fixating (gripping) mesh have been developed. Additionally, these tools give surgeons easier access to areas of the abdominal wall that are vulnerable and let them safely implant mesh where it is required, which is driving market expansion.

High prevalence of hernias worldwide is projected to fuel the market growth over the projected period. Inguinal hernia repairs account for 800,000 of the more than a million hernia repairs carried out in the country each year, according to the US FDA. Almost 0.95 million surgeries are performed each year to treat these hernias, which are particularly prevalent in developing nations. Rising hernia incidence rates are driving demand for effective hernia mesh devices which is anticipated to drive market expansion.

Segmentation

 By Hernia Type

The market is categorized into femoral hernia, incisional hernia, inguinal hernia, and others. In 2022, the inguinal hernia segment accounted for the highest revenue share due to the fact that nearly 80% of hernias are inguinal in origin. Additionally, it is 10 times more common in men than in women, requiring the cost of hernia surgery. Patient acceptability resulting from tension-free procedures and higher complications in traditional operating techniques are other factors contributing to this segment’s dominance. It is expected that femoral hernia will account for a sizable market share. Femoral hernias are more common in women than in males, particularly in older women due to larger form of a woman’s pelvis. Young children rarely get femoral hernias. In contrast to an inguinal hernia, it is a rare kind of hernia.

 By Mesh Type

The market is categorized into synthetic mesh and biologic mesh. In the global market, the biologic mesh segment accounted for the largest revenue share in 2022 owing to rising adoption of biologic mesh. Technological improvements are also predicted to drive the biologic mesh market during the projected period. The synthetic segment accounted for the biggest market share due to their high product availability, ease of access to the product materials, and affordability. In terms of the sales of mesh devices, the introduction of new products, ease of availability, and low rates were the main drivers of synthetic mesh market dominance. The absorbable mesh Dura Sorb was given CE Mark approval by Surgical Innovation Associates in September 2020. The product offers mechanical support and scaffolding as an alternative to biological or synthetic meshes that are permanent.

Regional Markets

In 2022, North America region accounted for the highest revenue in the hernia mesh devices market and is expected to maintain its dominance during the forecast period. This is attributed to huge population affected by the condition, better healthcare facilities, sedentary lifestyle habits, and widespread use of surgical meshes as a therapeutic option. Patients are being encouraged to choose open or laparoscopic surgery due to a favourable reimbursement scenario for hernia mesh. The government and corporate players in the industry have made precise payment codes and ratios available to patients. Europe had a substantial market share. Around 50,000 incisional hernia procedures are carried out in Germany each year, according to the German Federal Statistical Agency. With about 154,000 people suffering from the disease, hernias are a serious problem in France.

Competitor Insights

Some of the key players operating in the hernia mesh devices market are C. R. Bard, Inc, Medtronic, Inc., Atrium Medical, LifeCell Corporation, Ethicon, Inc., W. L. Gore and Associates, Inc., Covidien plc, and B. Braun Melsungen AG.

• For instance, Ethicon, a division of Johnson & Johnson, won the legal battle against polypropylene hernia mesh in March 2020. When implanted in a woman’s body, this mesh demonstrated substantial medical issues and harm.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including hernia type and mesh type from 2022 to 2033.

Report Scope:

Segmentation: Hernia Mesh Devices Market Report 2022 – 2033

Hernia Type (Revenue, USD Million), 2022 – 2033

• Femoral Hernia
• Incisional Hernia
• Inguinal Hernia
• Others

Mesh type (Revenue, USD Million), 2022 – 2033

• Synthetic Mesh
• Biologic Mesh

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA